Login to Your Account



Ampio's osteoarthritis of the knee data delayed by shipping temperature mishap

By Michael Fitzhugh
Staff Writer

Thursday, August 21, 2014
A shipping glitch that might have chilled to near freezing study packages of Ampio Pharmaceuticals Inc.'s late-stage osteoarthritis of the knee treatment, Ampion, will delay analysis of data from a pivotal study of the drug, the company said.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription